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Structured summary  1 
 2 
Objectives- To describe the technique of placement and clinical outcome following use of self-3 
inflating tissue expanders (STE) in twelve consecutive cases of reconstruction of distal cutaneous 4 
limb defects in dogs. 5 
Methods- Cases of distal cutaneous limb defect were included. Cases were divided into 3 groups 6 
based on location of the placement of the STEs: Group A (4 dogs) : on, or proximal to the elbow 7 
and stifle; Group B (4 dogs),  distal to the elbow/stifle and proximal to the carpus/ tarsus ; Group 8 
C (4 dogs) distal to the carpus and tarsus. Owner’s satisfaction and clinical outcome were 9 
documented.  10 
Results- Thirteen cases were originally included but one was  excluded because of incomplete 11 
follow-up. One case experienced premature removal of the STEs before expansion started. A 12 
mean of 5 STEs were implanted per dog (range 2-9). Devices were explanted after a mean of 24 13 
days (range 13-42 days).  Primary closure was achieved in 8/11 cases including all cases from 14 
Group A, and 75% and 33% of cases from Group B and C respectively. All incompletely 15 
reconstructed defects or cases of wound dehiscence healed by second intention.  Eight out of 12 16 
owners were satisfied.  17 
Impact of the work - Skin expansion using STE can be used as an alternative for the 18 
reconstruction of limb defects in dogs where direct primary closure would otherwise not be 19 
achievable.  Defects below the carpus and tarsus are more challenging to treat with STEs.  20 
 21 
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  24 
Introduction 25 
Tissue expansion was first described for soft tissue in the mid 20th century (Neumann, 1957).   It 26 
is now an established reconstructive technique in human surgery (Swan, 2007) and has a host of 27 
potential applications in veterinary surgery (Pavletic, 2010), in particular in the field of 28 
reconstructing limb cutaneous defects.   29 
Tissue expansion works by inducing ‘biological creep’ (generation of new tissue secondary to a 30 
chronic stretching forces) to the skin as opposed to producing tissue elongation beyond inherent 31 
extensibility, which is defined as “mechanical creep”. Mechanical creep induces a straightening 32 
of the convoluted collagen fibres, microfragmentation of the elastic fibres and mouvement of 33 
water from the collagen network. Conversely, the new tissue generated by “biological creep” 34 
(similar to events such as pregnancy, skin growth over tumours or obesity) undergoes completely 35 
different molecular and cellular changes with epidermal thickening and angiogenesis (Wilhelmi 36 
et al., 1998).  37 
Soft tissue expansion in the limbs of dogs has the advantage of additional skin for use in 38 
reconstructive procedures where there is otherwise limited local tissue available for the rotation 39 
or advancement of a skin flap (Swaim, 1980).  It is widely regarded that large skin defects of the 40 
limb, especially the distal limb are often difficult to manage (Spodnick et al., 1993); treatment 41 
often requires prolonged open wound care, second intention healing (Bright RM, 1985, Prpich et 42 
al., 2014) and/or the use of free skin grafts (Riggs et al., 2015). 43 
Since its inception, tissue expansion has been achieved by inflating a silicone balloon placed 44 
subcutaneously, using saline to fill the balloon through a subcutaneous (or occasionally an 45 
external) port.  The technique was first reported in veterinary medicine in 1989, in three horses, 46 
one heifer and one dog (Madison et al., 1989).  Subsequently the technique was refined more 47 
specifically to expand distal extremities in dogs (mid crus and mid ante brachium) in both 48 
experimental (Keller et al., 1994) and clinical settings (Spodnick et al., 1993, Keller et al., 1994).  49 
It was noted that even if the expanders were well tolerated with few complications, mild 50 
discomfort following percutaneous injections to fill the balloon was reported (Keller et al., 1994).  51 
Moreover the physical bulk of traditional balloon-type expanders often precluded their use in 52 
discrete anatomical locations (Swan et al., 2012). Furthermore the need for weekly expansion 53 
through a buried port can be painful and time consuming, may lead to an increased rate of port 54 
site infection with potentially greatly increased cost to the owner.  These limitations have led to 55 
the development of self-inflating tissue expanders. 56 
A self-inflating tissue expander is an osmotic expander formed of a hydrogel core (inert 57 
hygroscopic polymer) and external silicone coating. Once implanted, water is drawn by osmosis 58 
from the surrounding tissues into the device, which can spontaneously expand. The rate and 59 
extent of expansion is controlled by the external Silicone coating (Chummun et al., 2010). A self-60 
inflating tissue expander has many advantages over the traditional balloon devices.  The absence 61 
of a filling port and the ability of the hydrogel to conform to almost any configuration (Swan et 62 
al., 2011) enables this novel type of tissue expander to be used in anatomical locations that would 63 
otherwise be very difficult to utilise traditional expansion techniques using balloon devices. The 64 
indications for self-inflating tissue expander in skin reconstruction from the human literature 65 
include: the expansion of a flap to resurface an adjacent defect; the expansion of tissue prior to 66 
placement of an implant; and the pre-expansion of a flap or graft donor site (Sharpe, 1992). 67 
Among others they have been used for breast reconstruction, cleft palate repair, scar and burn 68 
resection (Ronert et al., 2004, Chummun et al., 2010, Lohana et al., 2012, Berge et al., 2001).  69 
The use of self-inflating tissue expanders has never before been reported in veterinary clinical 70 
species. The purpose of this prospective study is therefore to report the technique of placement 71 
and clinical outcome in dogs with limb defects that were managed using self-inflating tissue 72 
expanders across North America, UK and Europe.  This case series reports the use of a novel 73 
self-inflating anisotropic hydrogel tissue expander, which consists of a hydrogel core coated in 74 
medical grade silicone, manufactured to ISO 13485 standards for prospective human usage.   75 
 76 
 77 
Materials and Methods 78 
The study received ethical approval from the Institutional Ethical Review Committee of 79 
XXXXX. 80 
Cases managed with the a self-inflating tissue expander (STE) (Expaniderm, Oxtex Ltd , Oxford 81 
UK) (Figure 1) were prospectively included and  signalment, clinical history, reason for expander 82 
use, surgical technique, owner satisfaction, expander ease of use and clinical outcome including 83 
complications were recorded.   84 
The device expands in three phases:  a delay phase for 3-4 days after implantation when no 85 
expansion occurs to enable initial wound healing, then a controlled phase of linear expansion, 86 
followed by a plateau phase (reached within 2-4 weeks) when the device is fully expanded and 87 
will remain so until removed for the second-stage reconstruction.   88 
Dogs were included if they presented with a skin defect on a limb that could not be closed 89 
without a skin graft, flap or tissue expansion. The presence of active infection (evidenced by 90 
culture results and/or visual inspection) was a contra-indication. In the case of tumour resection, 91 
the preliminary cytology or histopathology results was first confirmed.  All therapeutic options 92 
were presented to owners; some guidance was offered but the decision to proceed with skin 93 
expansion was based on the owners’ decision.  Informed consent form was obtained from the 94 
owners. Cases were excluded if follow-up was not available or if the information with regards to 95 
tumour grading and / or staging was insufficient.  96 
Cases were divided into 3 groups based on anatomical positioning of the expanders.  Group A (4 97 
dogs) comprised of cases where the expanders were placed on, or proximal to, the elbow and 98 
stifle in the forelimb and hindlimb respectively. Group B (4 dogs) comprised of cases where 99 
expanders were placed distal to the elbow and proximal to the carpus in the forelimb and distal to 100 
the stifle but proximal to the tarsus in the hindlimb. Group C (4 dogs) comprised cases where 101 
expanders were placed distal to the carpus and tarsus.  102 
Indications for placing the expanders were as follows: prior to neoplastic tumour resection (n=5), 103 
prior to non-neoplastic tumour resection (n=3) and to aid primary wound closure of non-healing 104 
wounds (n=4).  Table 1 documents case descriptions and indications for expansion for all cases 105 
included in the study. 106 
Owner satisfaction was obtained by the veterinary surgeon performing the surgery once the 107 
wound had fully healed and was graded as either satisfied or not satisfied.  108 
Expander ease of use, as assessed by the veterinary surgeon, was graded as good (expanders 109 
implanted as planned including location and number of devices), fair (expanders not implanted as 110 
planned either location and numbers but leading to satisfactory / complete reconstruction) or poor 111 
(expanders not implanted as planned leading to partial reconstruction). 112 
Clinical outcome was defined according to the quality of wound closure and complications. 113 
Outcome was categorised into four groups:  114 
Excellent: no complications during implantation or skin expansion and full reconstruction 115 
Good: minor complications during implantation or expansion - full or partial 116 
reconstruction needing no further surgery post reconstruction  117 
Fair: major complications during implantation or expansion - full or partial reconstruction 118 
– no further surgical intervention required post reconstruction  119 
Poor: major complications during implantation or expansion requiring further care under 120 
sedation or anesthesia - partial or no reconstruction  121 
All dogs had two general anesthetics, one for the initial implantation and a second for the 122 
subsequent explantation and wound reconstruction.  Analgesia was provided with a combination 123 
of opioids and non-steroidal anti-inflammatory drugs (NSAID) as appropriate.  All dogs were 124 
induced, following premedication, using intravenous anaesthetic agents and maintained on 125 
Isofluane or Sevofluane. Prophylactic antimicrobials (including amoxicillin-clavulanic acid, 126 
second generation cephalosporin or metronidazole) were administered perioperatively to all dogs. 127 
Metronidazole was administered in only one dog based on culture and susceptibility testing. Dogs 128 
with open wounds were treated with antimicrobials based on culture and sensitivity testing 129 
wherever possible (2 cases). Postoperative infections were treated with antibiotics based on 130 
culture and sensitivity when possible.  The use of bandages and wound drains was according to 131 
the veterinary surgeon’s preference.   132 
 133 
Implantation technique-The implantation technique followed a series of specific guidelines:  (1) 134 
The incision for device insertion was made away from the proposed position of the device to  135 
minimise the risk of wound dehiscence during expansion; (2) The incision was made in normal 136 
skin, avoiding scar tissue, ulcerated or highly irradiated skin; (3) Care was taken so that the 137 
incision did not compromise the vascularity of the subsequent skin flap (Swan, 2007) and 138 
whenever possible the incision was made such that it preserved the proximal blood supply; (4) In 139 
oncological cases, the incision was made beyond the planned margins for tumour removal; (5) 140 
Blunt dissection was used to create a sub-cutaneous pocket and  the pocket was made sufficiently 141 
large to accommodate the STEs. This was checked using a trial device of the same size as the 142 
STE before final implantation; (6) When inserting the STEs, care is taken not to damage the 143 
silicone membrane coating the expander (such as the use of toothed forceps is  avoided); (7) 144 
Dead space was closed to prevent migration of the STEs; and (8) meticulous haemostasis is 145 
performed to reduce the risk of haematoma formation.  Incisions were closed in a routine fashion 146 
(Figure 2 and 3).  147 
Two expander types were used. They were both cylindrical with a diameter of 27mm. One 148 
expander device had a height of 5mm height and expanded to 18mm, whereas the alternative 149 
device had an initial height of 9mm and expanded to 25mm (Figure 1).  150 
 151 
Explantation technique-Devices were removed through the incision created at the leading edge of 152 
the skin flap whenever possible, however this was dependent on anatomical location. When the 153 
presence of an expander created a fibrous capsule, scoring or excision of the capsule allowed the 154 
elasticity of the overlying skin flap to be restored. During scoring care was taken not to 155 
compromise the vascularity of the skin flap. 156 
Following explantation, the skin defect was reconstructed fully or partially using the expanded 157 
skin either to aid direct primary closure or as an advancement flap.  158 
 159 
 160 
Results 161 
Thirteen consecutive cases of dogs with skin defects on the limb, managed with self-inflating 162 
tissue expanders between July 2014 and March 2016 were assessed.  All cases were operated on 163 
by different veterinary surgeons in a number of institutions.  One case was excluded from the 164 
present report due to loss of follow-up. For one further case, we could not report the outcome on 165 
reconstruction, expansion and wound closure following STE placement as the STEs had to be 166 
removed within 24 hours post placement (i.e. before any inflation had occurred). Therefore, 167 
outcome of implantation technique, rate and type of complications and procedure grading are 168 
reported on 12 cases whereas outcome of expansion, type of reconstruction techniques used, and 169 
wound closure are only reported on 11 cases.   170 
 171 
Implantation and Expansion- A mean of 5 STEs were implanted per dog (range 2-9). Devices 172 
were explanted after a mean of 24 days (range 13-42 days).  In 6 cases the STEs expanded as 173 
intended without complication.  In 2 cases, both in Group C, major complications were seen 174 
during expansion: in one dog the STEs extruded through the skin and in the other case the 175 
devices were removed early due to skin necrosis overlying the devices.  In another dog in group 176 
C, the devices were removed 24 hours post implantation (before expansion had started). In this 177 
case the un-expanded devices were placed on the palmar aspect of the carpal region and appeared 178 
to compromise blood supply to the distal forelimb, as evidenced by the profound change in 179 
colour of the leg distal to the STE placement site. Once the expanders were removed the leg 180 
returned to a completely normal colour.  One STE in group A ruptured by explantation although 181 
there was no macroscopic damage to the skin and full expansion of the skin was achieved. 182 
Rupture was thought to be due to incorrect STE handling at implantation.  In 3 cases minor 183 
complications occurred during expansion:  2 of these were incisional infections (suspected based 184 
on visual inspection) of which both dogs were being treated for an open wound. In 1 dog from 185 
group C there was minor tissue necrosis overlying one of the expanders, which did not affect the 186 
clinical outcome.  6 dogs were bandaged throughout expansion.  187 
 188 
Reconstruction-All dogs underwent a second general anaesthetic for reconstruction.  STEs were 189 
removed and in cases with a mass to be resected this was undertaken during the same anaesthetic 190 
episode.  In 6 cases the expanded skin was used as an advancement flap and in 5 cases the 191 
expanded skin was used to aid direct primary closure.  192 
 193 
Wound Closure- This was assessed in 11 of the 12 cases. Primary closure was achieved in 8/11 194 
(73%) cases. In group A, all 4 cases achieved primary closure (100%). In group B 3 of the 4 195 
(75%) cases achieved primary closure. In Group C 1 of the 3 (33%) cases achieved primary 196 
closure. Two of the cases from group A that had initial primary closure, subsequently 197 
encountered complications. One case resulted in complete wound dehiscence due to improper 198 
device positioning leading to excessive tension in the area of the defect where no tissue expander 199 
had been placed. In the second case there was partial ischemia of the advancement flap caused by 200 
inappropriate location of the implantation incision, which disrupted a significant portion of the 201 
blood supply to the advancement flap, resulting in nearly 90% of the skin appearing non-viable.  202 
In 3 cases (1 from group B and 2 from group C) primary closure was not achieved; however in all 203 
cases the resultant defect required to heal by second intention was greatly reduced due to the 204 
additional skin.   205 
Two of the three cases of group C failed to achieved primary closure due to tissue necrosis during 206 
expansion. In one case the STEs were removed prior to full expansion due to necrosis of the 207 
overlying tissue, this meant that there was insufficient skin generated for primary closure, 208 
however the skin that was expanded was viable and used to reduce the size of the defect.  In the 209 
second case in group C the STEs extruded prior to explantation, however extra skin was still 210 
generated and this was used to aid primary closure of the original defect and only a small open 211 
wound was left at the donor site which healed, without complication, via secondary intention.  In 212 
the one case from group B where primary closure was not achieved this was due to placement of 213 
the expanders.  Rather than being placed laterally and medially around the wound to be 214 
reconstructed, half the devices were placed proximally, which significantly reduced the ability to 215 
clinically use the skin that had expanded.  216 
 217 
Complications-Table 2 outlines all complications and procedure scoring outcomes.  One of the 12 218 
cases required additional surgery to remove the implants within 24 hrs after initial placement, as 219 
it was perceived that the implants were disrupting the blood supply to the leg. The 3 incompletely 220 
reconstructed defects and the 4 cases where dehiscence occurred all healed by second intention 221 
without the need for further surgical intervention.  Two dogs developed incisional infections, 222 
both of which were successfully treated with antibiosis (amoxicillin and clavulanic acid).  The 223 
infections did not affect expansion of the STEs, reconstruction or clinical outcome.  224 
Two dogs, both from group C, developed major complications during expansion.  One had STEs 225 
removed early and reconstruction carried out with partially expanded skin.  This resulted in a 226 
successful partial reconstruction that went on to heal without complication via secondary 227 
intention.  The second case experienced device extrusion, however there was still expanded skin 228 
that was used to aid the reconstruction.  The original defect was closed using the expanded skin 229 
and a small secondary donor defect was left to heal via second intention.  This went on to heal 230 
without complication.  231 
 232 
Procedure grading -On procedure grading 6/12 cases were scored as either excellent or good, 233 
5/12 being scored as fair and 1/12 scored as poor.  There were no complications seen at 234 
implantation and all surgeons scored the ease of use of the device as either good (7/12) or fair 235 
(5/12).  Owners were asked to score their experience as being either satisfied or not satisfied, 236 
8/12 owners reported that they were satisfied whereas 4/12 reported that they were not satisfied.  237 
 238 
Discussion  239 
This study is the first to present a range of indications, outcomes and complications associated 240 
with the use of self-inflating tissue expanders in a limited number of dogs. This type of tissue 241 
expander has never previously been used in veterinary clinical practice and this paper 242 
demonstrates an accurate and open documentation of the first 11 consecutive patients throughout 243 
Europe and North America.  As a prospective study it shows the initial learning curve of this 244 
product.   245 
Due to the ease of  use this product and its application in limb reconstruction, the majority of 246 
cases are seen and dealt with in first opinion practices.  This is reflected by the fact that 11 247 
different surgeons took part in this trial.  There was extensive support given by both a board 248 
certified veterinary surgeon and a human consultant reconstructive plastic surgeon, highly 249 
experienced in tissue expansion. Therefore this product was trialed in a realistic setting for its 250 
intended use. 251 
Of the 3 anatomical groups, group C had the least favorable outcomes and was the only group to 252 
have major complications.  The reason for complications distal to the carpus and tarsus is not 253 
fully understood but one hypothesis is that the pressure of the tissue expander device on the 254 
overlying skin exceeds the tissue perfusion pressure in this location thus leading to local tissue 255 
ischaemia and subsequent skin necrosis.  There was no evidence of skin necrosis when the 256 
devices were placed proximal to the carpus or tarsus (groups A and B).  Therefore it would be 257 
recommended that current self-inflating expanders only be placed distal to carpus or tarsus under 258 
careful consideration.  It is possible that a device that expands more gradually would potentially 259 
overcome the problem of tissue necrosis.   260 
Of the 8 cases with devices placed proximal to the tarsus and carpus, 6 had no complications 261 
throughout expansion and 2 cases had minor complications, thus demonstrating that use of these 262 
devices in this region is safe and effective. The minor complications were incisional infections 263 
which both resolved completely with antibiotic treatment.  None of the minor complications 264 
during expansion affected outcome.   265 
Precise and correct anatomical placement of the device is crucial to the quality and quantity of 266 
the expanded skin required for reconstruction (Hudson and Grob, 2005).  It is advised that an 267 
expander is placed a minimum distance from the defect and that the expander is 2.5-3.0 times the 268 
size of the defect to be reconstructed in order to succeed in primary closure (van Rappard et al., 269 
1988).  This assumption is based on studies performed on human skin, however studies carried 270 
out by Bartell and Mustoe found that there was no statistical difference between human and dog 271 
skin when tested for elastic and biomechanical properties and has been established as the best 272 
animal for tissue expansion (Bartell and Mustoe, 1989).  It is therefore not known whether the 273 
same principles should apply to canine skin expansion. However, incorrect placement was seen in 274 
2 cases in which less than excellent outcomes were achieved. In one case, rather than the devices 275 
being placed along the lateral and medial edges of the defect to be reconstructed 5 of the 8 276 
devices were placed proximal and medial.  This meant that all though the devices expanded as 277 
expected the extra skin created was difficult to utilize distally.  As previously stated in one case 278 
the incision for placing the STEs cut across the blood supply to the subsequent advancement flap, 279 
thereby resulting in its partial necrosis.   280 
The expanders tested in this study are anisotropic (only expanding in one vertical direction), 281 
therefore the additional skin gained is through the increase in height of the device. Thus the most 282 
efficient way to site the STE’s, in order to achieve the maximal amount of expanded skin is in a 283 
longitudinal configuration of STE’s along the length of the defect, or, where possible, one row 284 
either side of the defect.  285 
Complications arising from tissue expansion are relatively common, but the majority are of a 286 
minor nature (Malata et al., 1995).  In two retrospective studies by Casanova et al. (2001) and 287 
Pandya et al. (2001), the overall complication rates in lower limb tissue expansion in humans was 288 
cited as being 19.4% and 43% respectively, of which major complications were seen in 15.5% 289 
and 17% accordingly (Casanova et al., 2001) (Pandya et al., 2002).  290 
 291 
In this study the only group in which major complications were seen during expansion was those 292 
where the STEs were implanted distally to the carpus / tarsus. It is hypothesized that due to the 293 
distal location of the STEs the pressure exerted by the STEs exceeded the local tissue perfusion 294 
pressure thus resulting in tissue ischemia and subsequent tissue necrosis.  This is similar to the 295 
human literature, which reports that complications of the extremities are generally higher than 296 
those of the trunk and scalp (Hallock, 1987). The reason why one case developed a suspected 297 
distal limb ischemia following STE placement is unknown. This dog was the only one for whom 298 
the STEs were placed on the palmar aspect of the carpal region so it could be hypothesized that 299 
the STE were interrupting the blood supply to the distal leg from the median artery, the reason 300 
why the dorsal blood supply form the cranial superficial antebrachial artery did not suffice is 301 
unknown.  Following this complication, we are now recommending that STEs are not placed in 302 
the palmar region of the carpus.  303 
 304 
In cases of tumour resection, reconstruction was carried out before the margins were known. It is 305 
therefore possible that this method of reconstruction could be associated with cancer cells 306 
seeding, although we did not encounter this complication in our study. This issue might be more 307 
prevalent with tumours such as mast cell tumours and high grade STS , which typically require 308 
larger resection margins (Ryan et al., 2012). The very low occurrence of these tumours in our 309 
study population (no high grade STS and only one mast cell tumour) can explain why we did not 310 
encounter local recurrence due to cancer cells seeding.  We however believe that cancer cell 311 
seeding is a potentially serious issue to consider whilst using STE and, would advise against 312 
using those in the management of feline fibrosarcoma for this reason.  An alternative would be to 313 
resect the tumour at the time of STE placement. This was not advised as we estimated that the 314 
management of an open wound in addition to the management of the STE sites could potentially 315 
increase the risk of complications, including infection.   We also felt that the presence of an open 316 
wound could act as a “path of least resistance” and could increase the risk of premature STE 317 
dislodgment through the open wound, considering that STE were always placed on the edge of 318 
the proposed resection site. Ultimately the decision to not resect the tumour at the time of STE 319 
placement was based on subjective more than objective considerations.    320 
 321 
Traditional tissue expansion is performed over several weeks to months.  It was found that when 322 
skin was expanded proximal to the carpus and tarsus there were no detrimental effects of rapid 323 
two week expansion, compared with dogs where the device was expanded more gradually over 324 
four weeks (Keller et al., 1994).  This is supported by Mustoe et al. who concluded that rapid 325 
tissue expansion (two weeks in dogs) did not demonstrate any deleterious effects when compared 326 
with a more conventional regimen (Mustoe et al., 1987). This was confirmed in the present study. 327 
Mean expansion time in this study was 24 days. We started the study aiming for 28 days however 328 
it became apparent that there was little to be gained from leaving the expanders longer than 14 329 
days, which is our current expansion time recommendation.  330 
Even if the small number of included cases precludes drawing definitive conclusions, it does not 331 
presently appear that the incidence of complications is correlated with an increase number of STE 332 
placed. In fact, in two of the cases where the STEs were placed adjacent to open non-healing 333 
wounds, both wounds spontaneously started to contract.  It is hypothesised that was due to two 334 
reasons.  Firstly, the dissection of a subcutaneous pocket causes a delay phenomenon, which 335 
increases the rate of wound healing due to dilation of existing vessels (Taylor et al., 1992); 336 
secondly the mechanical stress placed on the skin by the expanding STE  may result in an 337 
increase in local angiogenesis.  In a prospective soft tissue reconstruction study in humans using 338 
traditional balloon expanders, increased expression of vascular endothelial growth factors 339 
(VEGF), a major angiogenic cytokine, was demonstrated compared to non-expanded control 340 
patients (Lantieri et al., 1998). 341 
 342 
In dogs, several options can be used for reconstruction on the limb including allowing a wound to 343 
heal via second intention (with or without the adjunct of negative wound pressure therapy), 344 
surgical closure by skin grafting, distant direct skin flaps (pouch or hinged flaps), pre-suturing of 345 
tissue surrounding the wound, placement of devices achieves gradual closure of the wound 346 
(Velcro pads, etc..). Of all these techniques, second intention healing and skin grafting are 347 
amongst the commonest used. Second intention healing has the advantage of requiring less 348 
surgical knowledge and may be attractive to an owner due to the lack of a surgical fee. It can be 349 
very useful in contaminated or infected wounds. However secondary intention is often protracted, 350 
may provide poor cosmetic results, and might result in functional disability due to scar tissue. 351 
Owners often underestimate the costs of prolonged dressings.  Prpich reported a 25.8% long-term 352 
complication in dogs that had secondary intention healing after wide local excisions of STS in the 353 
distal limb including intermittent disruption of the epidermis and decreased range of motion of 354 
the carpus due to scar contracture (Prpich et al., 2014).  Free skin grafts have the advantage of a 355 
single operation with quicker healing times, as well as potentially improved cosmetic and 356 
functional outcomes. They can however be technically more challenging with associated donor 357 
site morbidity. The success of the graft is mainly reliant on the establishment of a viable blood 358 
supply from the wound bed; and thus graft survival is more challenging, although possible, over 359 
exposed bone, joint, tendon or similarly poorly vascularized tissue.  Tissue expansion offers an 360 
alternative to these; it is a simple technique to perform utilising adjacent skin with an established 361 
blood supply, which can therefore be used to resurface any defect regardless of the underlying 362 
vascularity. Riggs et al reported the outcome of free skin grafts on 32 dogs; outcome was deemed 363 
successful if ≥ 75% of the original skin graft was viable 1 and 2 weeks after surgery.  They 364 
reported a success rate of 38% (Riggs et al., 2015) but did not evaluate the associated 365 
complications. 366 
 367 
From this study it can be concluded that soft tissue expansion can be used successfully as an 368 
alternative treatment for the reconstruction of limb defects in dogs where direct primary closure 369 
would otherwise not be achievable.  Further research into the uses of tissue expansion in 370 
veterinary species is warranted, both with respect to distal limb defects, but also in alternative 371 
surgical indications including potentially increasing the viability of random and axial pattern 372 
flaps by pre-expansion (Cherry et al., 1983) using the angiogenic properties of the “biological 373 
creep” induced by STEs . The use of pre-expanded flaps would be attractive for veterinary 374 
patients to potentially make them stronger to resist necrosis at their extremities, which is one very 375 
common problem with these flaps (Aper et al., 2003).  376 
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Figure legends 
 
Figure 1: Oxtex 27mm self-inflating tissue expander. Left :  before expansion ; right:  
after expansion  
 
Figure 2a.  Image of the metatarsal area of a dog presented for a lick granuloma (blue 
circle). The yellow dotted line represents the proposed incision to place the expanders 
(2 full circles). The two purple lines are the proposed incisions at the end of the 
expansion period. The purple line indicates the incision needed to create an 
advancement flap from the expanded skin. Alternatively a rotation flap (red line with 
two green arrows) could be undertaken 
 
Figure 2b. Placement of two expanders within a subcutaneous pocket, as per planned 
diagram in Figure 2a 
 
Figure  3: Step by step procedure from implantation to explanation of the STEs  
a: Incision along lateral margin, b: Implantation of 2 STEs, c: STE’s in situ post 
implantation, d: 14 days post implantation, e: Explantation of STEs, f: Removal of 
STS and lateral margins, g: Advancement flap created, h: Sutures removed 14 days 
post reconstruction.  STE = Self-inflating Tissue Expanders 
 
 
 
Table 1: Case description and reason for skin expansion  
 
Case number: Group  Age (years) No. of 
devices 
implanted  
Reason for 
reconstruction  
Size of defect 
to be 
reconstructed  
1 C 7 2 MCT 3.0 3.5 cm 
2 B 7 2 STS 2.5cm  
diameter 
3 C 7 2 NNM 3.0 x 3.5 cm 
4 A 13 2 NHW 4.0 cm 
diameter 
5 B 7 6 NHW 10.0 x 8.0 cm 
 
6 B 7 6 NHW Not recorded  
 
7 B Not recorded  8 STS 6.0 x 5.0 cm 
 
8 A 6 9 NNM 6.5 x 6.0 cm 
9 A 5 6 STS 2.5 x4.0 cm 
10 A 8 6 NHW 3.5 x 3.5 cm 
 
11 C Not known 2 STS 3.0 x 2.5cm 
12 C 13 2 Benign sebaceous 
adenomaNNM 
2.0cm diameter 
MCT (mast cell tumour), STS (soft tissue sarcoma), NNM (Non neoplastic mass), NHW (non healing wound), TN 
(tissue necrosis)  
 
 
 Table 2: Complications and Outcomes following skin expansion 
 
 
Dog case 
Number: 
Complications during 
expansion 
Reasons Major/Minor 
Primary 
closure 
achieved  
Complications post 
reconstruction  (Y/N) 
Procedure grading Owner outcome  
1 Major – Tissue necrosis N N – Healed via 2nd intention Fair Not Satisfied  
2 None Y N Excellent Satisfied 
3 Major – Tissue Necrosis N N – Healed via second 
intention  
Fair Satisfied 
4 None Y Y – 50% ischemic flap – 
Healed via second intention 
Fair Satisfied 
5 Minor - infection of 
wound 
Y N Good Satisfied 
6 None Y Y – 0.4cm tip of 
advancement flap ischemia 
– Healed via second 
intention 
Good Satisfied 
7 Minor – incisional 
infection  
N N – partial closure healed 
via second intention  
Good Not Satisfied 
8 None Y N Excellent  Satisfied 
9 None  Y  Y – Wound dehiscence– 
Healed via secondary 
intention  
Fair Satisfied 
10 None Y Y – Wound dehiscence 
healed via secondary 
intention 
Fair Not Satisfied  
11 Minor – Tissue Necrosis  Y N Good Satisfied  
12 Major- vascular 
compromise 
N/A N/A Poor  N/A 
a b c d
e f g h
